Rather than provide an exhaustive and rather tedious list of vasculitis mimics, this lecture will give clinical examples of patients initially thought to have a systemic vasculitis but where the final diagnosis was very different. Diabetes mellitus is a leading global metabolic disorder accompanied by the overwhelming burden of its associated complications. Hyperglycaemic-induced endothelial damage or endothelial dysfunction serves as the primary instigator for the development of microvascular disease. Diabetic neuropathy represents the majority of microvascular sequelae and is the renowned perpetrator of a variety of foot complications namely the Charcot foot (CF). CF is a debilitating medical emergency which is often mismanaged either due to a delayed diagnosis or lack of clinical expertise in the management of CF. Often, misdiagnosis during the acute stages of CF leads to irreversible and persistent joint destruction which may be refractory to medical or surgical treatment. Timely intervention with offloading measures is crucial during acute CF in ceasing active bone resorption. Current anti-resorptive agents may be considered as adjunctive therapy in combination with offloading. Novel agents are underway that will enable bone formation and suppress bone resorption. Disclosures: E.J. has received honoraria from Novonordisk, Sanofi, Lilly, Boehringer and Takeda. In this talk I will describe how the diagnosis of osteoporosis has changed with time, how to convey fracture risk and have shared decision making, and cases covering common daily clinical decision problems. The diagnosis of osteoporosis has evolved from the diagnosis being only considered if the patient had a fracture, to conceptual definitions that emphasised low bone density and abnormal bone turnover, then on to the WHO consensus statement in 1994 that defined osteoporosis as a T score of less than -2.5. Originally intended for research purposes, this T score threshold was rapidly used for both diagnosis and as a treatment threshold. Limitations of this were the arbitrary cut-offs and the relatively low sensitivity, so that that the majority of osteoporotic (low trauma) fractures in a population will occur in individuals with bone density values typically in the osteopenic range. These limitations of using T scores in isolation has resulted in a move to assessment of individualised risk that incorporates multiple risk factors (with or without bone density measurement) to help predict future fracture risk. This allows identification and treatment of individuals at high risk of fracture, as opposed to treating low bone density in isolation. Examples of fracture risk calculators include FRAX and QFracture.
Diabetes mellitus is a leading global metabolic disorder accompanied by the overwhelming burden of its associated complications. Hyperglycaemic-induced endothelial damage or endothelial dysfunction serves as the primary instigator for the development of microvascular disease. Diabetic neuropathy represents the majority of microvascular sequelae and is the renowned perpetrator of a variety of foot complications namely the Charcot foot (CF). CF is a debilitating medical emergency which is often mismanaged either due to a delayed diagnosis or lack of clinical expertise in the management of CF. Often, misdiagnosis during the acute stages of CF leads to irreversible and persistent joint destruction which may be refractory to medical or surgical treatment. Timely intervention with offloading measures is crucial during acute CF in ceasing active bone resorption. Current anti-resorptive agents may be considered as adjunctive therapy in combination with offloading. Novel agents are underway that will enable bone formation and suppress bone resorption. Disclosures: E.J. has received honoraria from Novonordisk, Sanofi, Lilly, Boehringer and Takeda. In this talk I will describe how the diagnosis of osteoporosis has changed with time, how to convey fracture risk and have shared decision making, and cases covering common daily clinical decision problems. The diagnosis of osteoporosis has evolved from the diagnosis being only considered if the patient had a fracture, to conceptual definitions that emphasised low bone density and abnormal bone turnover, then on to the WHO consensus statement in 1994 that defined osteoporosis as a T score of less than -2.5. Originally intended for research purposes, this T score threshold was rapidly used for both diagnosis and as a treatment threshold. Limitations of this were the arbitrary cut-offs and the relatively low sensitivity, so that that the majority of osteoporotic (low trauma) fractures in a population will occur in individuals with bone density values typically in the osteopenic range. These limitations of using T scores in isolation has resulted in a move to assessment of individualised risk that incorporates multiple risk factors (with or without bone density measurement) to help predict future fracture risk. This allows identification and treatment of individuals at high risk of fracture, as opposed to treating low bone density in isolation. Examples of fracture risk calculators include FRAX and QFracture. The clinical challenge now has changed from definition of the disease, to how to interpret risk of fracture, understand how that risk can be reduced with treatment and also to work with patients to explain fracture risk and potential treatment benefit versus treatment harm. Conveying risk and benefit can be tricky. In some clinical situations treatment benefit versus harm can be straightforward and intuitive. For other situations, such as osteoporosis where asymptomatic risk factors and measurements are being used, the situation is more complex. Multiple factors during a consultation can influence patient perception of fracture risk, and treatment benefit versus harm. They include, consulting style (e.g. paternalistic, informative or interpretive) and positively or negatively framing risk of fracture and treatment benefit and harm. Patients who understand risk can understand treatment decisions better and perhaps have better compliance with treatment. We also need to be aware that patients (and probably many clinicians) tend to overestimate benefit of treatment and underestimate harms of treatment. Overgeneralisation of pharmacological trials to clinical practice is one major reason. Cases from the Bone Clinic will be presented that emphasise daily decision problems about fracture risk and whether treatment is needed. Prior to this session it is advisable to have read the Royal College of Obstetricians General principles on how to convey risk -Clinical Governance Guidance 7 (2008). Disclosures: The author has declared no conflicts of interest.
I111 SJÖ GREN'S SYNDROME AND CURRENT MANAGEMENT
Elizabeth Price 1 1 Rheumatology, Great Western Hospital, Swindon, UNITED KINGDOM Sjö gren's syndrome is a chronic, immune-mediated, condition of unknown aetiology characterised by focal lymphocytic infiltration of exocrine glands. It typically affects women in their 40's and above, although up to 10% of cases occur in men and it is also seen in younger people. The prevalence in women in the UK has been estimated at 0.1-0.4%. Patients classically complain of drying of the eyes and mouth along with fatigue and joint pain and there is often a long delay between symptom onset and diagnosis. Other features include salivary gland swelling, joint inflammation, skin rashes, neuropathies, interstitial lung disease and a 5-10% lifetime risk of Bcell lymphoma. There is an association with autoimmune thyroid disease, coeliac disease and primary biliary cirrhosis. Systemic features include inflammatory arthritis, subacute lupus erythematosus, and immune thrombocytopaenia, vasculitis with purpura, salivary. The management of the glandular features includes conserving, replacing and stimulating secretions. Systemic features may require specific therapy and immunomodulatory treatment. Holistic management is important and many patients benefit from non-pharmacological therapies and general support. Newer, more targeted therapies are in development and may change the future management of the condition. Disclosures: The author has declared no conflicts of interest.
I112 AUTO-INFLAMMATORY DISEASES
Helen Lachmann 1 1 National Amyloidosis Centre, UCL Division of Medicine, Royal Free Campus, London, UNITED KINGDOM The systemic autoinflammatory syndromes are disorders of innate immunity which cause recurrent attacks of systemic inflammation usually with fever. There are both genetic and acquired forms of which the best recognised are: familial Mediterranean fever, TNF receptor associated periodic syndrome (TRAPS), cryopyrin associated periodic syndrome (CAPS), mevalonate kinase deficiency, periodic fever, adenitis, pharyngitis, and aphthous ulcer (PFAPA) and Schnitzler's syndrome. SAIDs can present at almost any age, although many onset in early childhood, 10% of patients will have their first symptoms after the age of 30 years. These are extremely rare conditions but of disproportionate importance firstly because untreated they can result in prolonged invasive investigations as well as severely impaired quality of life and recent advances have radically improved the ability to diagnose and treat them. They have also proved to be immensely informative about the role and regulation of the innate immune system and interleukin 1 in particular. Disclosures: H.L. corporate appointments; DSMB member IONIS. Consultancies; Novartis and SOBI. Honoraria; Novartis, SOBI and Takeda. Grants/research support; Novartis, SOBI.
I113 PERIPHERAL NEUROPATHIES
Ali S. M. Jawad 1 1 Rheumatology, Royal London Hospital, London, UNITED KINGDOM An entrapment neuropathy results from increased pressure on a nerve as it passes through an enclosed space. Compression of the median nerve as it travels through the carpal tunnel (CTS) is the commonest entrapment neuropathy. The estimated prevalence of CTS is 1-5%. There are at least another 50 entrapment neuropathies described, but are much less frequently encountered. A degree of direct compression against the nerve with associated nerve ischemia plays a role. However, many of these cases are considered to be a neuritis or due to trauma. 
